DRKS00028144尚未招募2 期
Personalized Therapy in Rheumatoid Arthritis 2.0 - PETRA 2.0
BKK Landesverband Bayern0 个研究点目标入组 440 人开始时间: 2022年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 440
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Adults are eligible to participate,
- •a. with a confirmed ICD 10 code M05. and M06. diagnosis
- •b. who are insured by the AOK Bayern or a participating BKK
- •c. who have submitted a declaration of participation in the PETRA 2.0 model project and
- •d. a valid data release for innovation fund projects for the PETRA 2.0 model project.
- •model project in accordance with § 75 SGB X (approval for the use of
- •routine data), and
- •e. who present themselves in a rheumatologists office participating in the study and
- •f. have sufficient knowledge of German to participate in the survey by means of questionnaires
排除标准
- •Confirmed diagnosis of fibromyalgia (ICD10 M79.7)
研究者
相似试验
已完成
不适用
BIOmarker-driven DEcision Study with Adalimumab (BIODESA)Rheumatoid arthritisISRCTN61158084niversity Hospital Regensburg (Universitätsklinikum Regensburg) (Germany)60
进行中（未招募）
3 期
Comparing the effectiveness of our tailor-made management approach for rheumatoid arthritis with routine care from a clinical, patient, as well as economic point of viewRheumatoid arthritisISRCTN16170070Erasmus University Medical Center300
招募中
4 期
PeRsonalIzed MEdicine in Rheumatoid Arthritis (PRIMERA trial): a multicenter, single-blinded, randomized controlled trial comparing usual care with a tailor-made approachSymmetrical (small) joint inflammation with or without auto-antibodies1000381610013361Rheumatoid ArthritisNL-OMON49359Erasmus MC, Universitair Medisch Centrum Rotterdam300
尚未招募
1 期
Management of Rheumatoid Arthritis.CTRI/2018/01/011192Central Council for Research in Homoeopathy
招募中
不适用
TApering strategies in Rheumatoid Arthritis remission induced by anti-TNF&classic DMARDs. Should we taper the classic DMARD or anti-TNF first?rheumatoid arthritisrheumatism10023213NL-OMON41388Erasmus MC, Universitair Medisch Centrum Rotterdam355